 |
 |
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Summaries for Patients are a service provided by Annals to help patients better understand the complicated and often mystifying language of modern medicine.
SUMMARIES FOR PATIENTS
The Association between Infection with Hepatitis C Virus and Diabetes
17 October 2000 | Volume 133 Issue 8 | Page I-40
Summaries for Patients are presented for informational purposes only. These summaries are not a substitute for advice from your own medical provider. If you have questions about this material, or need medical advice about your own health or situation, please contact your physician.
The summary below is from the full report titled "Prevalence of Type 2 Diabetes Mellitus among Persons with Hepatitis C Virus Infection in the United States." It is in the 17 October 2000 issue of Annals of Internal Medicine (volume 133, pages 592-599). The authors are SH Mehta, FL Brancati, MS Sulkowski, SA Strathdee, M Szklo, and DL Thomas.
What is the problem and what is known about it so far?
Infection with hepatitis C virus (HCV) can lead to liver problems. Chronic HCV infection has also been associated with illnesses not related to the liver. For example, some small studies suggest that diabetes is more common in people with HCV infection than in persons without it. Diabetes affects the body's ability to produce or respond to insulin, a hormone that regulates how the body uses carbohydrate, protein, and fat. There are two types of diabetes. Type 1 diabetes begins during childhood or young adulthood. People with type 1 diabetes do not make enough insulin. Type 2 diabetes, also known as adult-onset diabetes, interferes with the body's ability to respond to insulin. Over time, high blood sugar levels in both type 1 and type 2 diabetes can lead to such complications as blindness, kidney failure, and heart disease.
Why did the researchers do this particular study?
To see whether the likelihood of developing diabetes is increased among persons with HCV infection in the general adult population in the United States.
Who was studied?
Nearly 10,000 persons older than 20 years of age who participated in the Third National Health and Nutrition Examination Survey (NHANES III) during 1988 to 1994 and had complete evaluation for HCV infection and for diabetes.
How was the study done?
NHANES III was conducted by interviewing a sample of the U.S. civilian population in their own homes. The survey asked about personal characteristics, medical history, current and past medicine use, and health behaviors. Ninety-one percent of participants also had a physical examination and blood tests. The blood tests included measurement of the blood sugar level (to detect diabetes) and a test for HCV infection, which was done by the U.S. Centers for Disease Control and Prevention. The researchers compared the frequency of diabetes (type 1 and type 2) in persons with and those without HCV infection.
What did the researchers find?
Of the 9841 persons studied, 1242 had type 2 diabetes and 230 had HCV infection. People with HCV infection were more than three times more likely than people without HCV infection to have type 2 diabetes. None of the 19 persons with type 1 diabetes had HCV infection.
What were the limitations of the study?
This study suggests an association between type 2 diabetes and HCV infection, but it does not prove that the infection causes diabetes.
What are the implications of the study?
In the United States, type 2 diabetes occurs more often in people with HCV infection than it does in people without this infection.
Related articles in Annals:
This article has been cited by other articles:
|
|
 |
|
  D Marzouk, J Sass, I Bakr, M El Hosseiny, M Abdel-Hamid, C Rekacewicz, N Chaturvedi, M K Mohamed, and A Fontanet Metabolic and cardiovascular risk profiles and hepatitis C virus infection in rural Egypt Gut, August 1, 2007; 56(8): 1105 - 1110. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C.-S. Wang, S.-T. Wang, W.-J. Yao, T.-T. Chang, and P. Chou Hepatitis C Virus Infection and the Development of Type 2 Diabetes in a Community-based Longitudinal Study Am. J. Epidemiol., July 15, 2007; 166(2): 196 - 203. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Kamar, C. Mariat, M. Delahousse, J. Dantal, A. Al Najjar, E. Cassuto, N. Lefrancois, O. Cointault, G. Touchard, F. Villemain, et al. Diabetes mellitus after kidney transplantation: a French multicentre observational study Nephrol. Dial. Transplant., July 1, 2007; 22(7): 1986 - 1993. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Swaminathan, V. A. Fonseca, M. G. Alam, and S. V. Shah The Role of Iron in Diabetes and Its Complications Diabetes Care, July 1, 2007; 30(7): 1926 - 1933. [Full Text] [PDF]
|
|
|
|
|
|
K. G. Tolman, V. Fonseca, A. Dalpiaz, and M. H. Tan Spectrum of Liver Disease in Type 2 Diabetes and Management of Patients With Diabetes and Liver Disease Diabetes Care, March 1, 2007; 30(3): 734 - 743. [Full Text] [PDF]
|
|
|
|
 |
|
 M. F. Crutchlow and R. D. Bloom Transplant-Associated Hyperglycemia: A New Look at an Old Problem Clin. J. Am. Soc. Nephrol., March 1, 2007; 2(2): 343 - 355. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Simo, A. Lecube, J. Genesca, J. I. Esteban, and C. Hernandez Sustained Virological Response Correlates With Reduction in the Incidence of Glucose Abnormalities in Patients With Chronic Hepatitis C Virus Infection. Diabetes Care, November 1, 2006; 29(11): 2462 - 2466. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S.-S. KWEON, M.-H. SHIN, H.-J. SONG, D.-Y. JEON, and J.-S. CHOI SEROPREVALENCE AND RISK FACTORS FOR HEPATITIS C VIRUS INFECTION AMONG FEMALE COMMERCIAL SEX WORKERS IN SOUTH KOREA WHO ARE NOT INTRAVENOUS DRUG USERS Am J Trop Med Hyg, June 1, 2006; 74(6): 1117 - 1121. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Lecube, C. Hernandez, J. Genesca, and R. Simo Proinflammatory Cytokines, Insulin Resistance, and Insulin Secretion in Chronic Hepatitis C patients: A case-control study Diabetes Care, May 1, 2006; 29(5): 1096 - 1101. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Lecube, C. Hernandez, J. Genesca, and R. Simo Glucose Abnormalities in Patients with Hepatitis C Virus Infection: Epidemiology and pathogenesis Diabetes Care, May 1, 2006; 29(5): 1140 - 1149. [Full Text] [PDF]
|
|
|
|
 |
|
 J. I. Tsui, E. Vittinghoff, M. G. Shlipak, and A. M. O'Hare Relationship between Hepatitis C and Chronic Kidney Disease: Results from the Third National Health and Nutrition Examination Survey J. Am. Soc. Nephrol., April 1, 2006; 17(4): 1168 - 1174. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z. T. Bloomgarden Aspects of type 2 diabetes and related insulin-resistant States. Diabetes Care, March 1, 2006; 29(3): 732 - 740. [Full Text] [PDF]
|
|
|
|
|
|
A. Antonelli, C. Ferri, P. Fallahi, A. Pampana, S. M. Ferrari, F. Goglia, and E. Ferrannini Hepatitis C Virus Infection: Evidence for an association with type 2 diabetes Diabetes Care, October 1, 2005; 28(10): 2548 - 2550. [Full Text] [PDF]
|
|
|
|
|
|
L Fartoux, A Poujol-Robert, J Guechot, D Wendum, R Poupon, and L Serfaty Insulin resistance is a cause of steatosis and fibrosis progression in chronic hepatitis C Gut, July 1, 2005; 54(7): 1003 - 1008. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Knobler and A. Schattner TNF-{alpha}, chronic hepatitis C and diabetes: a novel triad QJM, January 1, 2005; 98(1): 1 - 6. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z. T. Bloomgarden Transplantation and Islet Topics Diabetes Care, January 1, 2005; 28(1): 213 - 219. [Full Text] [PDF]
|
|
|
|
|
|
A. Lecube, C. Hernandez, J. Genesca, J. I. Esteban, R. Jardi, L. Garcia, and R. Simo Diabetes Is the Main Factor Accounting for the High Ferritin Levels Detected in Chronic Hepatitis C Virus Infection Diabetes Care, November 1, 2004; 27(11): 2669 - 2675. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Kawaguchi, T. Yoshida, M. Harada, T. Hisamoto, Y. Nagao, T. Ide, E. Taniguchi, H. Kumemura, S. Hanada, M. Maeyama, et al. Hepatitis C Virus Down-Regulates Insulin Receptor Substrates 1 and 2 through Up-Regulation of Suppressor of Cytokine Signaling 3 Am. J. Pathol., November 1, 2004; 165(5): 1499 - 1508. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Lecube, C. Hernandez, J. Genesca, J. I. Esteban, R. Jardi, and R. Simo High Prevalence of Glucose Abnormalities in Patients With Hepatitis C Virus Infection: A multivariate analysis considering the liver injury Diabetes Care, May 1, 2004; 27(5): 1171 - 1175. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Antonelli, C. Ferri, P. Fallahi, M. Sebastiani, C. Nesti, L. Barani, R. Barale, and E. Ferrannini Type 2 diabetes in hepatitis C-related mixed cryoglobulinaemia patients Rheumatology, February 1, 2004; 43(2): 238 - 240. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C.-S. Wang, S.-T. Wang, W.-J. Yao, T.-T. Chang, and P. Chou Community-based Study of Hepatitis C Virus Infection and Type 2 Diabetes: An Association Affected by Age and Hepatitis Severity Status Am. J. Epidemiol., December 15, 2003; 158(12): 1154 - 1160. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Schattner and H. Knobler Clinical Aspects of Chronic Hepatitis C Infection JAMA, September 17, 2003; 290(11): 1453 - 1453. [Full Text] [PDF]
|
|
|
|
|
|
S. L. Flamm Clinical Aspects of Chronic Hepatitis C Infection--Reply JAMA, September 17, 2003; 290(11): 1453 - 1454. [Full Text] [PDF]
|
|
|
|
|
|
V Ratziu, M Saboury, and T Poynard Worsening of steatosis and fibrosis progression Gut, September 1, 2003; 52(9): 1386 - 1387. [Full Text]
|
|
|
|
|
|
B. R. Shah and J. E. Hux Quantifying the Risk of Infectious Diseases for People With Diabetes Diabetes Care, February 1, 2003; 26(2): 510 - 513. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. J. Greenberger Update in Gastroenterology Ann Intern Med, January 7, 2003; 138(1): 45 - 53. [Full Text] [PDF]
|
|
|
|
|
|
Z. T. Bloomgarden Obesity, Hypertension, and Insulin Resistance Diabetes Care, November 1, 2002; 25(11): 2088 - 2097. [Full Text] [PDF]
|
|
|
|
|
|
O. Oncul, C. Top, and T. Cavuthlu Correlation of Serum Leptin Levels With Insulin Sensitivity in Patients With Chronic Hepatitis-C Infection Diabetes Care, May 1, 2002; 25(5): 937 - 937. [Full Text]
|
|
|
|
|
|
R. D. Bloom, V. Rao, F. Weng, R. A. Grossman, D. Cohen, and K. C. Mange Association of Hepatitis C with Posttransplant Diabetes in Renal Transplant Patients on Tacrolimus J. Am. Soc. Nephrol., May 1, 2002; 13(5): 1374 - 1380. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. R. Bacon, A. M. Di Bisceglie, J. R. Korb, H. L. Tillmann, K. C. Herold, S. Himelhoch, R. J. de Knegt, A. P. van den Berg, B. P. Bell, B. D. Walker, et al. Hepatitis C Virus Infection N. Engl. J. Med., November 8, 2001; 345(19): 1425 - 1428. [Full Text] [PDF]
|
|
|
|
 |
|
 A. Mason Viral Induction of Type 2 Diabetes and Autoimmune Liver Disease J. Nutr., October 1, 2001; 131(10): 2805S - 2808. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Knobler and A. Schattner Association of Hepatitis C and Diabetes Mellitus Ann Intern Med, July 17, 2001; 135(2): 141 - 141. [Full Text] [PDF]
|
|
|
|
|
|
R. Paris Association of Hepatitis C and Diabetes Mellitus Ann Intern Med, July 17, 2001; 135(2): 141 - 142. [Full Text] [PDF]
|
|
|
|
|
|
G. J.M. Alexander An Association between Hepatitis C Virus Infection and Type 2 Diabetes Mellitus: What Is the Connection? Ann Intern Med, October 17, 2000; 133(8): 650 - 652. [Full Text] [PDF]
|
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Article
